About ASTELLAS PHARMA INC.

ASTELLAS PHARMA INC.

Astellas Pharma Inc. is a pharmaceutical company headquartered in Tokyo, Japan. The company develops and markets pharmaceutical products for a wide range of diseases, including cancer, cardiovascular disease, and infectious diseases. The company's products are sold in over 140 countries and territories worldwide.

News Releases

Astellas and Kelonia Therapeutics Enter into Research and License Agreement to Develop Novel Immuno-Oncology Therapeutics

_↗ prnewswire.com

Feb 15, 2024

Astellas Submits Supplemental New Drug Application in Japan for PADCEV™ (enfortumab vedotin (genetical recombination)) with KEYTRUDA® (pembrolizumab (genetical recombination)) for First-Line Treatment of Advanced Bladder Cancer

_↗ astellas.com

Jan 31, 2024

Astellas to Acquire Propella Therapeutics

_↗ astellas.com

Nov 15, 2023

Disclaimer : All logos and trademarks on this website are the property of their respective owners. The information on this website is not a medical or investment related advice. The information about the company might not reflect the most current or accurate information. Please refer to the company's respective website for the most accurate information.